Stock Events

Stock Events

Nichi-Iko Pharmaceutical Co 

¥35
1
+¥0+0% Tuesday 06:15

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 21
¥703,847,000
Jun 21
¥703,847,000
Dec 20
¥1,055,770,500
Jun 20
¥1,055,770,500
Dec 19
¥1,055,770,500
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-1,317.21
-881.89
-446.56
-11.24
Expected EPS
N/A
Actual EPS
-718.36

Financials

-58.63%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
179.06BRevenue
-104.98BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4541.TSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
TAK
Mkt Cap59.2B
Takeda Pharmaceutical Company Limited is a major competitor in the pharmaceutical industry, offering a wide range of products that compete directly with Nichi-iko's offerings in various therapeutic areas.

About

Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin " antagonist, angiotensin " antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
Show more...
CEO
Mr. Yuiichi Tamura
Employees
2656
Country
JP
ISIN
JP3687200000

Listings

0 Comments

Share your thoughts

FAQ

What is Nichi-Iko Pharmaceutical Co stock price today?▼
The current price of 4541.TSE is ¥35 JPY — it has increased by +0% in the past 24 hours. Watch Nichi-Iko Pharmaceutical Co stock price performance more closely on the chart.
What is Nichi-Iko Pharmaceutical Co stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nichi-Iko Pharmaceutical Co stocks are traded under the ticker 4541.TSE.
What is Nichi-Iko Pharmaceutical Co revenue for the last year?▼
Nichi-Iko Pharmaceutical Co revenue for the last year amounts to 179.06B JPY.
What is Nichi-Iko Pharmaceutical Co net income for the last year?▼
4541.TSE net income for the last year is -104.98B JPY.
Does Nichi-Iko Pharmaceutical Co pay dividends?▼
Yes, 4541.TSE dividends are paid semi-annual. The last dividend per share was 10 JPY. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Nichi-Iko Pharmaceutical Co have?▼
As of April 11, 2026, the company has 2,656 employees.
In which sector is Nichi-Iko Pharmaceutical Co located?▼
Nichi-Iko Pharmaceutical Co operates in the Healthcare sector.
When did Nichi-Iko Pharmaceutical Co complete a stock split?▼
Nichi-Iko Pharmaceutical Co has not had any recent stock splits.
Where is Nichi-Iko Pharmaceutical Co headquartered?▼
Nichi-Iko Pharmaceutical Co is headquartered in Toyama, JP.